Karolina Ollik et al. 2026. NEW DISEASE-MODIFYING THERAPIES IN ALZHEIMER’S DISEASE: A CLINICAL REVIEW OF LECANEMAB AND DONANEMAB. International Journal of Innovative Technologies in Social Science. 2, 1(49) (Mar. 2026). DOI:https://doi.org/10.31435/ijitss.1(49).2026.4885.